New risk assessment tool for mild COVID patients The matrix is designed to give GPs an indication of the risks patients have of developing more severe disease.
At-risk COVID patients in WA directed to GPs for antiviral access The WA Department of Health has changed the mechanism for prescribing antiviral treatments through its COVID Care at Home program.
Push for more detail on COVID-19 oral antivirals impact Experts highlight ‘crucial’ need for more understanding about how newly released oral antiviral drugs are performing in the broader population.
Special COVID-19 podcast - Antivirals The Good GP interviews Kerry Fitzsimons and Dr Claire Italiano on COVID antiviral medications, exploring what treatments are available for patients with COVID, the contraindications and indications, and the GP’s role.
Antivirals and military parachuted in as aged care struggles with Omicron With more than 40% of residential facilities managing ongoing outbreaks, the military has been deployed and antivirals are being delivered. But how much help will they provide?
What GPs need to know about the new COVID antivirals Both oral antiviral COVID-19 treatments are now available, with significant restrictions, on the PBS.
GPs will soon be able to prescribe two new COVID treatments The TGA’s provisional approval of the first oral treatments for COVID-19 in Australia has been welcomed as a ‘new hope’.
How important is Pfizer’s new COVID-19 antiviral likely to be? The US pharmaceutical company has said clinical trial results of its new COVID-19 pill are ‘game-changing’. Experts give newsGP their take on its likely impact.
Australia secures 300,000 courses of COVID antiviral The supply agreement could mean molnupiravir is being used to treat COVID-19 by early 2022, provided it is approved by the TGA.
Potential COVID treatment reduces viral count in mice lungs by 99.9% And experts believe this form of medicine will translate to similar outcomes in humans, making it a ‘viable therapy’ for COVID-19.